Ipamorelin + Mod GRF Oral Strips For Natural GH Release: Peptides Launched

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Neuvera has announced its Ipamorelin + Mod GRF dissolvable oral peptide strips as part of its Growth and Build Routine, designed to support daily recovery, sleep quality, and natural growth hormone signaling without injections.

-- Neuvera has added Ipamorelin + Mod GRF dissolvable oral peptide strips to its product lineup, positioning them as the foundation of its Growth and Build Routine. Delivered in pre-measured strips that dissolve in seconds, the product is designed to support natural growth hormone signaling, sleep quality, and recovery without the need for injections.

More information is available at https://neuveralife.com/products/ipamorelin-cjc-1295

The two active compounds in the strips are ipamorelin and mod GRF (CJC No DAC), both associated with growth hormone signaling through complementary pathways. According to Rite Aid, ipamorelin works by binding the ghrelin/GH-secretagogue receptor on the pituitary gland, triggering pulsatile growth hormone release to support the body's restorative cycles and physical readiness. Neuvera describes ipamorelin as a selective secretagogue, noting that its targeted action does not meaningfully affect cortisol, prolactin, or other hormonal processes.

Neuvera pairs ipamorelin with mod GRF, which acts on a different receptor pathway for complementary effects. According to the company, mod GRF supports rhythm-based restorative signaling, sleep quality, and balanced daily recovery rhythms. Together, the two peptides are designed to support physical resilience and performance across workouts and daily activity.

The strips are pre-measured and ready to use without mixing, cold storage, or needles. Users place a strip on the roof of the mouth, where it dissolves in seconds. Each strip incorporates Neuvera's proprietary RapidRelease technology, a blend of absorption enzymes including beta cyclodextrin and sodium caprate. According to the company, these enzymes temporarily expand the mucosal lining of the mouth and encapsulate the peptide molecule during transit, allowing it to bypass first-pass digestion and enter systemic circulation directly. Neuvera reports an absorption rate of 92.5%, which it says is on par with injectables, a figure validated using glutathione, the largest molecule in its product line.

The strips are available as a single box of 30 units or as a 90-day supply. Neuvera also offers a Growth and Build Routine bundle that pairs the Ipamorelin + Mod GRF strips with its NAD+ strips for daily use.

More information about Neuvera and its products is available at https://neuveralife.com/

Contact Info:
Name: Rachel Candler
Email: Send Email
Organization: Neuvera
Address: 3 Wing Dr Cedar Knolls, Hanover, New Jersey 07927, United States
Website: https://neuveralife.com/

Source: PressCable

Release ID: 89204611

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.15
-3.52 (-1.41%)
AAPL  338.40
-2.67 (-0.78%)
AMD  607.87
-22.76 (-3.61%)
BAC  55.47
-1.23 (-2.17%)
GOOG  339.16
-1.92 (-0.56%)
META  715.62
-36.04 (-4.79%)
MSFT  509.22
-6.95 (-1.35%)
NVDA  228.86
+3.79 (1.68%)
ORCL  132.60
-4.50 (-3.28%)
TSLA  357.45
-14.66 (-3.94%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.